The present meta‐analysis reported that young patients with suboptimally‐controlled type 1 diabetes mellitus and treated with CSII regimen undertook Ramadan fasting with lower rates of hyperglycemia, ketosis and breaking fast compared with those treated with either premixed insulin or MDI regimen. The gene discussed is INS; the disease is Hyperglycemia.